AN2 Therapeutics, Inc. (ANTX)
4.81
+0.47
(+10.83%)
USD |
NASDAQ |
Apr 27, 16:00
4.81
0.00 (0.00%)
After-Hours: 20:00
AN2 Therapeutics EPS Diluted (TTM) : -1.164 for Dec. 31, 2025
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Relmada Therapeutics, Inc. | -1.470 |
| ACADIA Pharmaceuticals, Inc. | 2.288 |
| Alnylam Pharmaceuticals, Inc. | 2.257 |
| Savara, Inc. | -0.5344 |
| BioMarin Pharmaceutical, Inc. | 1.782 |